179 related articles for article (PubMed ID: 36565260)
1. [Coxsackievirus B infection and pathogenesis of type 1 diabetes].
Nekoua MP; Mercier A; Vergez I; Morvan C; Mbani CJ; Sane F; Lobert D; Engelmann I; Romond MB; Alidjinou EK; Hober D
Virologie (Montrouge); 2022 DéCembre 01; 26(6):415-430. PubMed ID: 36565260
[TBL] [Abstract][Full Text] [Related]
2. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus.
Nekoua MP; Alidjinou EK; Hober D
Nat Rev Endocrinol; 2022 Aug; 18(8):503-516. PubMed ID: 35650334
[TBL] [Abstract][Full Text] [Related]
3. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
Sané F; Moumna I; Hober D
Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
[TBL] [Abstract][Full Text] [Related]
4. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
Tracy S; Drescher KM; Chapman NM; Kim KS; Carson SD; Pirruccello S; Lane PH; Romero JR; Leser JS
J Virol; 2002 Dec; 76(23):12097-111. PubMed ID: 12414951
[TBL] [Abstract][Full Text] [Related]
5. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B.
Hyöty H; Leon F; Knip M
Expert Rev Vaccines; 2018 Dec; 17(12):1071-1083. PubMed ID: 30449209
[TBL] [Abstract][Full Text] [Related]
6. Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes.
Alidjinou EK; Sané F; Engelmann I; Geenen V; Hober D
Discov Med; 2014 Nov; 18(100):273-82. PubMed ID: 25425468
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention.
Carré A; Vecchio F; Flodström-Tullberg M; You S; Mallone R
Endocr Rev; 2023 Jul; 44(4):737-751. PubMed ID: 36884282
[TBL] [Abstract][Full Text] [Related]
8. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.
Tracy S; Drescher KM
Ann N Y Acad Sci; 2007 Apr; 1103():143-51. PubMed ID: 17376828
[TBL] [Abstract][Full Text] [Related]
10. The CVB and etiology of type 1 diabetes.
Drescher KM; Tracy SM
Curr Top Microbiol Immunol; 2008; 323():259-74. PubMed ID: 18357774
[TBL] [Abstract][Full Text] [Related]
11. Combating coxsackievirus B infections.
Alhazmi A; Nekoua MP; Mercier A; Vergez I; Sane F; Alidjinou EK; Hober D
Rev Med Virol; 2023 Jan; 33(1):e2406. PubMed ID: 36371612
[TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect.
Stone VM; Butrym M; Hankaniemi MM; Sioofy-Khojine AB; Hytönen VP; Hyöty H; Flodström-Tullberg M
Diabetes; 2021 Dec; 70(12):2871-2878. PubMed ID: 34497136
[TBL] [Abstract][Full Text] [Related]
13. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.
Kanno T; Kim K; Kono K; Drescher KM; Chapman NM; Tracy S
J Virol; 2006 Jun; 80(11):5637-43. PubMed ID: 16699045
[TBL] [Abstract][Full Text] [Related]
14. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models.
Jaïdane H; Sané F; Gharbi J; Aouni M; Romond MB; Hober D
Diabetes Metab Res Rev; 2009 Oct; 25(7):591-603. PubMed ID: 19621354
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous type 1 diabetes onset in mother and son coincident with an enteroviral infection.
Hindersson M; Elshebani A; Orn A; Tuvemo T; Frisk G
J Clin Virol; 2005 Jun; 33(2):158-67. PubMed ID: 15911432
[TBL] [Abstract][Full Text] [Related]
16. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes.
Stone VM; Hankaniemi MM; Svedin E; Sioofy-Khojine A; Oikarinen S; Hyöty H; Laitinen OH; Hytönen VP; Flodström-Tullberg M
Diabetologia; 2018 Feb; 61(2):476-481. PubMed ID: 29151123
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Beta Cell Dysfunction Associated With Viral Infection.
Petzold A; Solimena M; Knoch KP
Curr Diab Rep; 2015 Oct; 15(10):73. PubMed ID: 26280364
[TBL] [Abstract][Full Text] [Related]
18. Coxsackievirus B Tailors the Unfolded Protein Response to Favour Viral Amplification in Pancreatic β Cells.
Colli ML; Paula FM; Marselli L; Marchetti P; Roivainen M; Eizirik DL; Op de Beeck A
J Innate Immun; 2019; 11(4):375-390. PubMed ID: 30799417
[TBL] [Abstract][Full Text] [Related]
19. Fighting Enteroviral Infections to Prevent Type 1 Diabetes.
Nekoua MP; Mercier A; Alhazmi A; Sane F; Alidjinou EK; Hober D
Microorganisms; 2022 Apr; 10(4):. PubMed ID: 35456818
[TBL] [Abstract][Full Text] [Related]
20. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes.
Jaïdane H; Hober D
Diabetes Metab; 2008 Dec; 34(6 Pt 1):537-48. PubMed ID: 18951821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
